Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study

PURPOSE: This study aimed to compare treatment outcomes for bloodstream infections (BSI) caused by a piperacillin/tazobactam (PIP/TAZ)-susceptible E. coli among three patient groups: BSI caused by ampicillin/sulbactam (AMP/SLB)-resistant isolates treated with PIP/TAZ, BSI caused by AMP/SLB-sensitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobudic, Selma, Bahrs, Christina, Schneider, Lisa, Paulussen, Emilia, Bartonickova, Lucie, Hagel, Stefan, Starzengruber, Peter, Burgmann, Heinz, Pletz, Mathias W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665230/
https://www.ncbi.nlm.nih.gov/pubmed/37462895
http://dx.doi.org/10.1007/s15010-023-02074-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665230/
https://www.ncbi.nlm.nih.gov/pubmed/37462895
http://dx.doi.org/10.1007/s15010-023-02074-z

Ejemplares similares